Volume 2.27 | Jul 22

Mammary Cell News 2.27 July 22, 2010.
In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  Events Subscribe  |  Unsubscribe


Gene Find Offers Breast Cancer Hope  ShareThis
Researchers have identified the key role played by the gene c35 in causing the spread of HER2 positive breast cancer. [Press release from University of Edinburgh discussing advanced online publication in the British Journal of Cancer]




Study: Fish-Oil Supplements May Cut Breast-Cancer Risk
Researchers at the Fred Hutchinson Cancer Research Center surveyed more than 35,000 postmenopausal women in Western Washington and found that those who took omega-3 fish-oil supplements had a 32 percent lower incidence of breast cancer. [Press release from Seattle Times discussing advanced online publication in Cancer Epidemiology, Biomarkers & Prevention]

Study Reports on Cleaning Products, Beliefs About Breast Cancer, and Breast Cancer Risk
Women who reported the highest combined cleaning product use had a doubled risk of breast cancer compared to those with the lowest reported use. [Press release from Silent Spring Institute discussing online publication in Environmental Health]

Studies Gauge Techniques for Measuring Breast Density – a Predictor of Cancer
Two new studies announced this week have tested three different methods for accurately measuring breast density , the relative portion of tissue to fat in a woman’s breasts and a strong indicator of breast cancer risk. [Press release from EurekAlert! discussing research presented at the 52nd Annual Meting of the American Association of Physicists in Medicine]


CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)


Reprogramming Human Cancer Cells in the Mouse Mammary Gland
Here, researchers report that human embryonal carcinoma cells proliferate and produce differentiated mammary epithelial cell progeny when mixed with mouse mammary epithelial cells and inoculated into the epithelium-free mammary fat pads of athymic nude mice. [Cancer Res]

6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance
The data show that 6-thioguanine(6TG) efficiently kills BRCA2-defective tumors and suggest that 6TG may be effective in the treatment of advanced tumors that have developed resistance to poly(ADP-ribose) polymerase inhibitors or platinum-based chemotherapy. [Cancer Res]

Janus Kinase 2 is Required for the Initiation but Not Maintenance of Prolactin-Induced Mammary Cancer
To assess the importance of Janus kinase 2 (Jak2)/signal transducer and activator of transcription 5 signaling during mammary cancer initiation and progression, researchers generated a prolactin receptor-induced mammary cancer model that allows the functional ablation of the Jak2 gene in the mammary epithelium before and after neoplastic transformation. [Oncogene]

Post-Transcriptional Mechanisms Contribute to the Suppression of the ErbB3 Negative Regulator Protein Nrdp1 in Mammary Tumors
Here, researchers demonstrate that transgenic expression of Nrdp1 cDNA in the mouse mammary gland is not sufficient to suppress elevated ErbB3 levels or tumor initiation and growth in ErbB2 transgenic mice. [J Biol Chem]

Dissecting the Transcriptional Networks Underlying Breast Cancer: NR4A1 Reduces the Migration of Normal and Breast Cancer Cell Lines
The purpose of the study was to identify the role of NR4A1 in normal mammary epithelial and breast cancer cell biology. [Breast Cancer Res]

A Gene on the HER2 Amplicon, C35, is an Oncogene in Breast Cancer Whose Actions are Prevented by Inhibition of Syk
C35 functions as an oncogene in breast cancer cell lines. Drug targeting of C35 or Syk kinase might be helpful in treating a subset of patients with HER2-amplified breast cancers. [Br J Cancer]

miR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells
In this study, researchers showed that lactoferrin gene expression and function are directly targeted by miR-214 in HC11 and MCF7 cells. [J Nutr]

Negative Regulation of UCP2 by TGF(Beta) Signaling Characterizes Low and Intermediate-Grade Primary Breast Cancer
Through mechanistic analyses, researchers show a synergistic link between UCP2 and established cellular pathways in conferring grade-associated functional phenotypes. [Cell Death & Disease]


Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
Researchers determined whether the association between breast density and breast cancer risk and cancer severity differs according to menopausal status and postmenopausal hormone therapy use. [J Clin Oncol]

Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort
Current use of fish oil was associated with reduced risk of breast cancer. [Cancer Epidemiol Biomarkers Prev]

Self-Reported Chemicals Exposure, Beliefs About Disease Causation, and Risk of Breast Cancer in the Cape Cod Breast Cancer and Environment Study: a Case-Control Study
This population-based case-control study investigated whether use of household cleaners and pesticides increases breast cancer risk. [Environ Health]


Genentech Provides Update from Avastin FDA Advisory Committee Meeting
Genentech, Inc. announced that the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin’s U.S. label.


Susan G. Komen for the Cure Awards $1.2 Million for Innovative Breast Cancer Research at the Karmanos Cancer Institute and Wayne State University
Four researchers from Detroit, Michigan’s Barbara Ann Karmanos Cancer Institute and Wayne State University will receive a total of $1.2 million from Susan G. Komen for the Cure® to help advance research to better detect, prevent and eliminate breast cancer. [Barbara Ann Karmanos Cancer Institute Press Release]

YWCA Boston Receives $50,000 Avon Foundation Grant
The Avon Foundation Breast Care Fund has awarded a $50,000 grant to YWCA Boston’s breast cancer education, early detection and survivorship program, building on a long-standing partnership between the YWCA Boston and the Avon Foundation for Women. [YWCA]

CIHR Funding Boosts Queen’s Research Into Breast Cancer Treatment
Peter Greer (Pathology and Molecular Medicine) has received $1.6 million for two research projects aimed at developing new treatments to slow tumour growth in breast cancer. [Queen’s University Press Release]

Prospective Grant of Exclusive License: The Development of Human Therapeutics for the Treatment of Cancer [National Institutes of Health, United States]

Pre-Application Meeting for Request for Applications (RFA-CA-10-016) for the Clinical Proteomic Technologies for Cancer Initiative (CPTC): Proteome Characterization Centers (NOT-CA-10-031) [National Institutes of Health, United States]

Notice of Intent to Publish a Request for Applications for Tumor Microenvironment Network (TMEN) (NOT-CA-10-032) [National Institutes of Health, United States]


2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2)
August 2-4, 2010
Singapore City, Singapore

Select Biosciences 3rd Annual Stem Cells Europe Conference
August 24-25, 2010
Edinburgh, Scotland

Select Biosciences Inaugural Cellular Therapy Summit
August 24-25, 2010
Edinburgh, Scotland

Stem Cells USA & Regenerative Medicine Congress 2010
September 13-15, 2010
Philadelphia, United States

15th Congress of the European Society of Surgical Oncology (ESSO)
September 15-17, 2010
Bordeaux, France

2010 World Cancer Congress
August 18-21, 2010
Shenzhen, China

NEW Cellular Therapy of Cancer Symposium – ATTACK Project Meeting
September 24-27, 2010
Montpellier, France

2010 Breast Cancer Symposium
October 1-3, 2010
Washington, DC, United States

NEW 2nd International Inflammatory Breast Cancer Conference
October 6-7, 2010
Marseille, France

35th European Society for Medical Oncology (ESMO) Congress
October 8-12, 2010
Milan, Italy

International Symposium on Breast Cancer Prevention: Nutrition, Communications, Public Policy
October 18-19, 2010
West Lafayette, United States

16th World Congress of the International Society of Senology
October 20-22, 2010
Valencia, Spain

The 2010 American Institute for Cancer Research (AICR) Annual Research Conference on Food, Nutrition, Physical Activity & Cancer
October 21-22, 2010
Washington, DC, United States

6th National Cancer Research Institute (NCRI) Conference
November 7-10, 2010
Liverpool, United Kingdom

NEW 33rd Annual San Antonio Breast Cancer Symposium
December 8-12, 2010
San Antonio, Texas, United States


Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

Have we missed an important article or publication in Mammary Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Mammary Cell News: Archives  |  Events  |  Subscribe  |  Contact Us